Unknown

Dataset Information

0

EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells.


ABSTRACT: The enhancer of zeste homolog 2 (EZH2), known as a member of the polycomb group (PcG) proteins, is an oncogene overexpressed in a variety of human cancers. Here, we found that EZH2 correlated with poor survival of oral squamous cell carcinoma (OSCC) patients using immunohistochemistry staining. EZH2 overexpression led to a significant induction in tumour glycolysis, Epithelial-mesenchymal transition (EMT), migration and invasion of OSCC cells. Conversely, silencing of EZH2 inhibited tumour glycolysis, EMT, migration and invasion in OSCC cells. Ectopic overexpression of EZH2 increased phosphorylation of STAT3 at pY705 and decreased FoxO1 expression, and FoxO1 expression was enhanced when inhibiting STAT3. In addition, EZH2 overexpression led to a significant decrease in FoxO1 mRNA levels in nude mice xenograft. These results indicated that regulation of EZH2 might have the potential to be targeted for OSCC treatment.

SUBMITTER: Zheng M 

PROVIDER: S-EPMC6787444 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells.

Zheng Min M   Cao Ming-Xin MX   Luo Xiao-Jie XJ   Li Li L   Wang Ke K   Wang Sha-Sha SS   Wang Hao-Fan HF   Tang Ya-Jie YJ   Tang Ya-Ling YL   Liang Xin-Hua XH  

Journal of cellular and molecular medicine 20190731 10


The enhancer of zeste homolog 2 (EZH2), known as a member of the polycomb group (PcG) proteins, is an oncogene overexpressed in a variety of human cancers. Here, we found that EZH2 correlated with poor survival of oral squamous cell carcinoma (OSCC) patients using immunohistochemistry staining. EZH2 overexpression led to a significant induction in tumour glycolysis, Epithelial-mesenchymal transition (EMT), migration and invasion of OSCC cells. Conversely, silencing of EZH2 inhibited tumour glyco  ...[more]

Similar Datasets

| S-EPMC6848388 | biostudies-literature
| S-EPMC8269286 | biostudies-literature
| S-EPMC6495520 | biostudies-literature
| S-EPMC9293979 | biostudies-literature
| S-EPMC7066035 | biostudies-literature
| S-EPMC7183334 | biostudies-literature
| S-EPMC3381367 | biostudies-literature
| S-EPMC10826434 | biostudies-literature
| S-EPMC8005699 | biostudies-literature
| S-EPMC5929094 | biostudies-literature